Archive for September, 2008

Nursing - Pitting one antiemetic against another

Friday, September 26th, 2008

The drug prochlorperazine (Compazine) relieves uncomplicated nausea and vomiting significantly better than promethazine (Phenergan), according to recent study results. Researchers randomly assigned 84 patients who arrived in the ED with acute gastritis or gastroenteritis to receive one of the two dru…

Nursing Law's Regan Report - The nurse’s role in determining testamentary capacity.(Nursing Law Case on Point)

Wednesday, September 24th, 2008

CASE ON POINT: In Re. Purported Last Will of Patton, 2004 WL 3030543 N.E.2d–DE

Related Results

Phener…

Deseret News (Salt Lake City) - Patrick Kennedy crashes his car near the Capitol

Friday, September 19th, 2008

Rep. Patrick Kennedy crashed his car near the Capitol early Thursday, and a police official said he appeared intoxicated. Kennedy said he had had no alcohol before the accident.
Kennedy, D-R.I., addressed the issue after a spate of news reports. His initial statement said: “I consumed no alcohol prior to the incident.”‘
Later…

Business Wire - Hi-Tech Pharmacal receives FDA approval to market generic form of phenergan with dextromethorphan syrup

Thursday, September 18th, 2008

AMITYVILLE, N.Y.–(BUSINESS WIRE)–Aug. 7, 1996–Hi-Tech Pharmacal has received ANDA approval from the FDA for Promethazine Hydrochloride and Dextromethorphan Hydrobromide Syrup, 6.25 mg/15 mg per 5 m…

Australian Nursing Journal - Warning on Phenergan use.(Focus Briefs)(Brief Article)

Wednesday, September 17th, 2008

The antiemetic and antihistamine drug promethazine (Phenergan) may cause respiratory depression and death if it is given to children less than two years old, the US Food and Drug Administration (US FDA) has warned.

Related Results

Independent, The (London) - TODAY’S NUMBER

Sunday, September 14th, 2008

132

Related Results

Phenergan contraindicated under age 2.(News)

Vesicant ex…

Pediatric News - Phenergan contraindicated under age 2.(News)

Tuesday, September 9th, 2008

Phenergan (promethazine) is now contraindicated in children younger than 2 years because of possible fatal respiratory depression and should be used cautiously in other pediatric patients, according to a new black box warning recently requested by the Food and Drug Administration.

The agency requested that the black box warning be added to Phenergan’s label after a review of the drug’s pediatric adverse events.

Related Results

Pediatric News - Are lawyers deciding medical care?(Letters)(Brief Article)(Letter to the Editor)

Saturday, September 6th, 2008

As I understand it, there are no hard data that Phenergan alone has caused any adverse outcomes in infants.
Is this a case of the lawyers deciding on medical care?
I would like to be educated on …

Most Popular
Public Speaking: 7 Secrets Of Great Public Speakers
Business Plan Sample
10 Jobs That Pay $30 An Hour
5 Regular Mistakes In Public Speak…

Learning About Migraine Treatments

Thursday, September 4th, 2008

If you suffer from migraine headaches you know how debilitating they can be. You have probably tried a number of migraine treatments with little or no relief as well, which makes you feel like banging your head against the wall….